Compare CMMB & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMMB | LUCY |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 7.4M |
| IPO Year | 2023 | 2021 |
| Metric | CMMB | LUCY |
|---|---|---|
| Price | $1.08 | $0.86 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 102.3K | ★ 119.3K |
| Earning Date | 11-19-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | 63.39 |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | ★ $2,661,669.00 |
| Revenue This Year | N/A | $170.51 |
| Revenue Next Year | N/A | $205.56 |
| P/E Ratio | $27.00 | ★ N/A |
| Revenue Growth | N/A | ★ 62.65 |
| 52 Week Low | $1.01 | $0.65 |
| 52 Week High | $3.44 | $2.02 |
| Indicator | CMMB | LUCY |
|---|---|---|
| Relative Strength Index (RSI) | 24.22 | 49.91 |
| Support Level | N/A | $0.66 |
| Resistance Level | $1.89 | $1.17 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 5.36 | 60.00 |
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.